February 10, 2021

Clinical impact of PCSK9 inhibitor on stabilization and regression of lipid-rich coronary plaques: a near-infrared spectroscopy study

HOHideaki OtaFujita Health University Hospital HOHiroyuki OmoriOsaka Dental University MKMasanori KawasakiCardiac Imaging

Key Points

Key points are not available for this paper at this time.

Abstract

The lipid component of non-culprit coronary plaques was significantly decreased by PCSK9i. The effects of statin combined with PCSK9i might be attributed to the stabilization and regression of residual vulnerable coronary plaques in patients with CAD.

Perguntar à IA

Bookmark

View Full Paper

Cite This Study

Ota et al. (Wed,) studied this question.

synapsesocial.com/papers/69d8c8eb183921ebcaae3ab9 https://doi.org/https://doi.org/10.1093/ehjci/jeab034

Perguntar à IA

Bookmark

View Full Paper